狼疮性肾炎
CXCL16型
系统性红斑狼疮
免疫学
VCAM-1
肾炎
医学
趋化因子
泌尿系统
尿
蛋白尿
内科学
肾
炎症
疾病
细胞粘附分子
CXCL10型
ICAM-1
作者
Tianfu Wu,Chun Xie,Hong W. Wang,Xin J. Zhou,Noa Schwartz,Sergio Calixto,Meggan C. Mackay,Cynthia B. Aranow,Chaim Putterman,Chandra Mohan
出处
期刊:Journal of Immunology
[American Association of Immunologists]
日期:2007-11-01
卷期号:179 (10): 7166-7175
被引量:180
标识
DOI:10.4049/jimmunol.179.10.7166
摘要
In an effort to identify potential biomarkers in lupus nephritis, urine from mice with spontaneous lupus nephritis was screened for the presence of VCAM-1, P-selectin, TNFR-1, and CXCL16, four molecules that had previously been shown to be elevated in experimental immune nephritis, particularly at the peak of disease. Interestingly, all four molecules were elevated approximately 2- to 4-fold in the urine of several strains of mice with spontaneous lupus nephritis, including the MRL/lpr, NZM2410, and B6.Sle1.lpr strains, correlating well with proteinuria. VCAM-1, P-selectin, TNFR-1, and CXCL16 were enriched in the urine compared with the serum particularly in active disease, and were shown to be expressed within the diseased kidneys. Finally, all four molecules were also elevated in the urine of patients with lupus nephritis, correlating well with urine protein levels and systemic lupus erythematosus disease activity index scores. In particular, urinary VCAM-1 and CXCL16 showed superior specificity and sensitivity in distinguishing subjects with active renal disease from the other systemic lupus erythematosus patients. These studies uncover VCAM-1, P-selectin, TNFR-1, and CXCL16 as a quartet of molecules that may have potential diagnostic significance in lupus nephritis. Longitudinal studies are warranted to establish the clinical use of these potential biomarkers.
科研通智能强力驱动
Strongly Powered by AbleSci AI